Savvy Updates, 5/16/22: Dexcom G7 European Launch, Lilly Introduces Mounjaro, RECALL Skittles/Starburst/LifeSavers, Tattoo-like Sensors, A History of Insulin Pumps
Dexcom Chief Tech Officer Leach discusses G7’s European launch and FDA review, expanding Dexcom One as written by Ricky Zipp for MedTechDrive.com, 10 May 2022. Dexcom’s newest continuous glucose monitoring system, called G7, was released last quarter...
Savvy Updates, 5/9/22: FDA Stops Vertex Study, Extended Wear Infusion Set, Salaries at Dexcom
Unwelcome surprise for Vertex as FDA slaps hold on phase 1/2 diabetes cell therapy study was reported by Annalee Armstrong for FierceBiotech.com, 2 May 2022. Vertex’s new diabetes cell therapy early study of VX-880 was placed on clinical hold after...
Savvy Update 5/2/22: Ypsomed/Abbott/CamDiab, New Glucose & Ketone Monitoring, News from ATTD 2022, Luna for MDI, Pharmasens Combined Pump
Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes was announced by Ypsomed.com, on 27 April 2022. Ypsomed, Abbott, and CamDiab will work to accelerate the development of an automated insulin delivery...
Savvy Update 4/25/22: Two Types of T1D, Your Gut & BG, Hunger & Brain, CGM Monitoring Start-Ups, Physician Compensation Report 2022, Team-based Diabetes Care
Type 1 diabetes is not one but two distinct conditions, defined by diagnosis age was published by the University of Exeter, 16 March 2020. Children who are diagnosed with type 1 diabetes under the age of seven have a different form (or...
Savvy Update, 4/11/22: Legislation Targets Abusive Pharma Practices, 1st US Implant of Eversense E3 CGM, Voice May Predict Heart Disease, Ultrasound to Treat T2D, Bioprinted Pancreas
Maloney, Stabenow, and Smith Lead Colleagues in Introducing Legislation to Target Abusive Pharmaceutical Business Practices was published by the House Committee on Oversight and Reform, 7 April 2022. Rep. Carolyn B. Maloney, Chairwoman of the House...
More Diabetes Blogs